600079 ST人福医药
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额280,9262,518,7242,164,2651,967,2502,441,071
投资活动产生之现金流量净额(26,291)(390,372)(742,025)(1,224,718)1,226,790
筹资活动产生之现金流量净额188,933(1,801,100)(1,497,997)(2,105,567)(4,244,942)
汇率变动对现金及现金等价物的影响(18,624)(685)(23,867)16,29948,452
现金及现金等价物净增加/(减少)424,944326,567(99,624)(1,346,737)(528,629)
期初现金及现金等价物余额3,217,3872,890,8202,990,4454,337,1814,865,811
期末现金及现金等价物余额3,642,3313,217,3872,890,8202,990,4454,337,181